Ä«Å×°í¸®
|
Cytokines & Growth Factor
|
CAT.NO
|
LGP-12-024
|
PRODUCT
|
IL-36RA, Mouse (Murine Interleukin-36 Receptor Antagonist Protein)
|
SIZE
|
10ug, 100ug, 500ug
|
PRICE
|
KRW 285,000, 880,000, 2,569,000
|
Technical Parameters
Synonyms |
IL-1HY1, IL-1 delta, IL-1F5, IL-1H3, IL-1L1 |
Accession |
Q9QYY1 |
GeneID |
54450 |
Source |
Escherichia coli. |
Molecular Weight |
Approximately 16.9 kDa, a single non-glycosylated polypeptide chain containing 154 amino acids. |
Quantity |
10µg/100µg/500µg |
AA Sequence |
VLSGALCFRM KDSALKVLYL HNNQLLAGGL HAEKVIKGEE ISVVPNRALD ASLSPVILGV QGGSQCLSCG TEKGPILKLE PVNIMELYLG AKESKSFTFY RRDMGLTSSF ESAAYPGWFL CTSPEADQPV RLTQIPEDPA WDAPITDFYF QQCD |
Purity |
> 95 % by SDS-PAGE and HPLC analyses. |
Biological Activity |
Measured by its ability to inhibit IL-36¥ã induced IL-6 production by human PBMCs. |
Physical Appearance |
Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation |
Lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4. |
Endotoxin |
Less than 1 EU/µg of rMuIL-36RA as determined by LAL method. |
Reconstitution |
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ¡Â -20 ¡ÆC. Further dilutions should be made in appropriate buffered solutions. |
Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 ¡ÆC as supplied. - 1 month, 2 to 8 ¡ÆC under sterile conditions after reconstitution. - 3 months, -20 to -70 ¡ÆC under sterile conditions after reconstitution. |
Usage |
This material is offered by Korea Lugen Sci for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE. |
Reference |
1. Born TL, Smith DE, Garka KE, et al. 2000. J Biol Chem. 275:41528. 2. Dunn EF, Gay NJ, Bristow AF, et al. 2003. Biochemistry. 42:10938-44. 3. Barton JL, Herbst R, Bosisio D, et al. 2000. Eur J Immunol. 30:3299-308. 4. Debets R, Timans JC, Homey B, et al. 2001. J Immunol. 167:1440-6. 5. Towne JE, Renshaw BR, Douangpanya J, et al. 2011. J Biol Chem. 286:42594-602. |
Background |
Interleukin-36 receptor antagonist (IL-36RA) is a secreted protein which belongs to the interleukin 1 cytokine family (IL-1 family) and it is predominantly expressed in keratinocytes but not in fibroblasts, endothelial cells or melanocytes. IL-36RA has been reported to antagonize the biological activity of IL-36¥á (IL-1F6), IL-36¥â (IL-1F8), and IL-36¥ã (IL-1F9). Furthermore, it could constitute part of an independent signaling system analogous to interleukin-1 alpha (IL-1A), beta (IL-1B) receptor agonist and interleukin-1 receptor type I (IL-1R1). In addition, The receptor for IL-36RA has not been positively identified. Indirect evidence suggests it is IL-1Rrp2. Recombinant murine interleukin-36 RA contains 154 amino acid residues and it shares 91 % a.a. sequence identity with human IL-36RA. |
|
÷ºÎÆÄÀÏ
|
|
|
|
|